Given the fluctuating situation in the Gulf region because of the US-Iran conflict, there is no guarantee that the market will not fall fur...

As nothing can be ruled out on the street, be prepared for anything. Now, what is the probability that the bears will be chased away from t...

If you are putting fresh money into the stock market (or even looking to rejig your existing portfolio), it would be best not to react to w...

The promoter has raised ₹350 crore in debt from Modulus Alternatives to help with the buyout. The fund, borrowed at the promoter level, is ...

JPMorgan maintained an overweight rating on Tata Steel with a target price of Rs 140. “Large PAT loss was driven by inventory NRV hit in Eu...

Gross margin was impressive at 21.7%, upheld by private label share and store expansion was on track with 614 stores in H1FY23. It had a ‘b...

Edelweiss said Medplus’s sheer scale and value proposition puts it way ahead in the league. "Its integrated supply chain, aggressive store ...

Amidst the Covid pandemic, MedPlus Health Service became the first standalone pharmacy retail chain to get listed on the Indian bourses. Th...

The stock opened at ₹1,040 and closed at ₹1,120.85 on the NSE. The strong listing comes after its ₹1,398-crore IPO was subscribed about 53 ...

“The platform which we have built over the last 15 years will hold us in good stead as we continue to expand rapidly. ”

The majority of analysts are bullish on the counter and recommend it to hold for the long run. They are bullish on the growth prospects, de...

The Rs 1,398.30 crore IPO of Medplus Health Services was open for subscription between December 13-15. The company sold its shares in the r...

In the unofficial market, the pharmacy retailer is commanding a mild premium of Rs 90-100 per share, a premium of 10-12 per cent over its i...

At the issue price, MedPlus would trade at 3.1x FY21 P/S & 40x FY21 EV/EBITDA, said Aditya Birla Capital, which has suggested investors wit...

The company has allotted 52.51 lakh equity shares to anchor investors at Rs 796 apiece, aggregating to Rs 417.98 crore, according to a circ...

The initial public offering (IPO) comprises fresh issuance of equity shares worth Rs 600 crore and an offer for sale (OFS) of up to equity ...

Hyderabad-based Natco Pharma expects to sell 10 million capsules of Natflu, the generic version of Tamiflu-Oseltamivir, used to treat swine...